CorMedix signage outside a biopharmaceutical laboratory, signifying the company's promising clinical-stage results. Key Points CorMedix is best known for its catheter lock solutions, products designed to reduce the risk of infection for dialysis patients. DefenCath is one of the company's leading products, having recently achieved promising results in both reducing catheter-related infections and related hospitalizations. The company's other leading candidate, REZZAYO, should see Phase III trial data i ...